Therapeutic device

< Back
  • Home
  • high-intensity focused ultrasound (HIFU)

    • high-intensity focused ultrasound (HIFU)

    Product Name: Ablatherm®, Sonablate®
    Country: France (FR)

    Haute Autorité de Santé

    Outcome Measure

    a. Efficacy: mortality, side effects, long term survival (-overall, -cancer-specific, -without metastasis, -without second treatment, -without biochemical or disease relapse), long-term side effects, quality of life (p. 6)<br>b. Safety: Operative and postoperative complications (p. 6)

    Body Classification

    Male Reproductive System

    Publication

    High Intensity Focalized Ultrasound for the treatment of localized prostate cancer (Health Technology Assessment, 2010, Summary)

    Device Type

    Therapeutic device

    Device Category

    Treatment of disease

    Risk Classification

    IIa

    Indication

    localized prostate cancer

    ICD-10

    C61

    Feedback